Objective-Recent genome-wide association studies identified a variant rs7575840 in the apolipoprotein B (APOB) gene region as associated with low-density lipoprotein (LDL) cholesterol. However, the underlying functional mechanism of this variant, which resides 6.5 kb upstream of APOB, has remained unknown. Our objective was to investigate rs7575840 for association with refined apoB-containing lipid particles, for replication in a Mexican population, and for its underlying functional mechanism. Methods and Results-Our data show that rs7575840 is associated with serum apoB levels (Pϭ4.85ϫ10 Ϫ10 ) and apoB-containing lipid particles, very small very-low-density lipoprotein, intermediate lipoprotein, and LDL particles (Pϭ2ϫ10 Ϫ5 to 9ϫ10 Ϫ7 ) in the Finnish Metabolic Syndrome in Men study sample (nϭ7710). Fine mapping of the APOB region using 43 single-nucleotide polymorphisms replicated the association of rs7575840 with apoB in a Mexican study sample (nϭ2666, Pϭ3.33ϫ10 Ϫ5 ). Furthermore, our transcript analyses of adipose RNA samples from 175 subjects in the Finnish Metabolic Syndrome in Men study indicate that rs7575840 alters expression of APOB (Pϭ1.13ϫ10 Ϫ10 ) and a regional noncoding RNA (BU630349) (Pϭ7.86ϫ10 Ϫ6 ) in adipose tissue. Conclusion-It has been difficult to convert genome-wide association study associations into mechanistic insights. Our data show that rs7575840 is associated with serum apoB levels and apoB-containing lipid particles, as well as influencing expression of APOB and a regional transcript BU630349 in adipose tissue. We thus provide evidence how a common genome-wide significant single-nucleotide polymorphism, rs7575840, may affect serum apoB, LDL cholesterol, and total cholesterol levels. (Arterioscler Thromb Vasc Biol. 2011;31:1201-1207.) 
ther establishing the role of APOB in LDL metabolism. We hypothesized that rs7575840, SNPs in LD with it, or both may function as a regulatory cis-expression quantitative trait locus, and we tested 175 adipose RNA samples from the Finnish METSIM study for allele-specific expression of transcripts within the APOB gene region.
Methods
The study design was approved by the ethics committees of the participating centers, and all subjects gave written informed consent.
Study Samples

METSIM Cohort
The Finnish population-based cohort of the METSIM study was collected at the University of Kuopio, Kuopio, Finland as described previously. 4 The METSIM cohort consisted of 7710 male subjects, aged 50 to 70 years, randomly selected from the population of Kuopio in eastern Finland. Each patient participated in an interview session to measure factors that may affect cardiovascular disease risk, including prescription drug use, weekly exercise, metabolites, cardiovascular family history, and other health questions. Phenotypic determinations were performed as described previously. 4 Plasma lipoproteins from the METSIM subjects were fractionated using proton nuclear magnetic resonance into high-density lipoprotein, LDL, intermediate lipoproteins, very-low-density lipoproteins (VLDL), and chylomicron subclasses, as described previously. 5, 6 
Mexican Hypertriglyceridemia Cases and Controls
A total of 2666 Mexican hypertriglyceridemic cases and controls were recruited at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, as described previously. 7 Briefly, the inclusion criteria were fasting serum triglycerides Ͼ2.3 mmol/L (200 mg/dL) for the cases and Ͻ1.7 mmol/L (150 mg/dL) for the controls. Exclusion criteria were type 2 diabetes mellitus, morbid obesity (body mass index [BMI] Ͼ40 kg/m 2 ), and (for controls) the use of lipid-lowering drugs. Fasting lipid levels were measured using commercially available standardized methods as described previously. 7 Serum LDL-C levels were calculated using the Friedewald formula for subjects with triglycerides Ͻ400 mg/dL.
Genotyping and Real-Time Polymerase Chain Reaction
The SNP rs7575840 was genotyped in the METSIM study sample using the Sequenom genotyping platform. The 43 SNPs in the APOB region (Ϯ100 kb) were genotyped in the Mexican study sample using both Pyrosequencing and Illumina BeadArray technology platforms. The SNPs were in Hardy-Weinberg equilibrium (PϾ0.05) in both study samples and had a genotyping call rate Ͼ90%. The real-time polymerase chain reaction of 175 METSIM RNAs for BU630349 was performed using Quantitect Reverse Transcription kit (Qiagen), as described in detail in the Supplemental Methods, available online at http://atvb.ahajournals.org.
Tagging of the APOB Region in the Mexican Study Sample
We genotyped 43 SNPs for the APOB region (Ϯ100 kb) in 2310 subjects of the Mexican dyslipidemic study sample. Using Haploview version 4.2 8 and Northern and Western European ancestry from the Centre d'Etude du Polymorphisme Humain (CEPH) collection (CEU) HapMap data, we calculated that these 43 SNPs capture 90% of the variation, with minor allele frequency of Ն5% and r 2 Ն0.80. We used the CEU HapMap data for these calculations as the coverage of the Mexican American HapMap data is still incomplete.
Microarray Data and Gene Expression Analysis in METSIM Fat Biopsy Samples
A total of 175 METSIM subjects underwent subcutaneous fat biopsies for adipose RNA isolation. The RNA isolation was per-formed according to the manufacturer's instructions (Qiagen). The adipose RNA samples were hybridized to the Illumina HT-12 version 3.0 expression chips. Genome Studio was used to perform quantile normalization and background subtraction. An absent call was made with the detection probability values Ͼ0.01. Probes with Ͼ50% absent calls were excluded from the analysis. All METSIM subjects were unrelated males. Microarray data for the transcripts in the APOB gene region (Ϯ500 kb) will be submitted to the National Center for Biotechnology Information's Gene Expression Omnibus repository in minimum information about a microarray experimentcompliant format (GSE27666).
To test whether the APOB or BU630349 expression in 175 METSIM fat biopsies was influenced by the rs7575840 genotypes, we log transformed the APOB and BU630349 expression values. Expression values more than 4 standard deviations from the mean were removed from the analysis. The 2-sided Student t test was performed to compare the means between carriers of the T rare allele and the homozygous common G group (ie, dominant model). The evolutionary conserved region Vista browser was used to look at the conservation of BU630349 across 13 species.
Association Analysis in METSIM
To test for association between the SNPs and lipid traits and the lipoprotein subclasses, we performed multivariate linear regression analysis for the additive genetic model using SPSS software. Trait values were adjusted for age-and log-transformed BMI. Subjects with BMI Ͼ40, lipid lowering medication, diabetes, or a trait value greater than 4 standard deviations from the mean were excluded from the analysis, leaving 5054 METSIM individuals in the association analyses. Pearson correlation analyses were performed between the raw lipid particle measurements and gene expression (APOB and BU630349). The gene expression values were log transformed, and values greater than 4 standard deviations from the mean were removed.
Association Analysis in Mexican Hypertriglyceridemic Cases and Controls
To unify the association analysis with the METSIM analysis, we performed the multivariate linear regression analysis using SPSS software by adjusting the trait values for age, sex, log-transformed BMI, and hypertriglyceridemia case-control status. Subjects with BMI Ͼ40, lipid lowering medication, diabetes, or a trait value greater than 4 standard deviations from the mean were excluded from the statistical analysis. Bonferroni correction (43 tested SNPs; PϽ0.001) was used to evaluate significance. We did not correct for 3 tested traits, as apoB, LDL-C, and TC are known to be highly correlated.
Individual Ancestry Analyses
We had genotype data for 82 evenly distributed ancestry informative markers for 2310 of the Mexican hypertriglyceridemia case-control samples. 7 These ancestry informative markers were selected based on a published list of European/Amerindian ancestry informative markers 9 and were used to calculate individual ancestry estimates using Structure 2.2 software, 10 as described in the Supplemental Methods.
Results
The SNP rs7575840 resides in the APOB region, 6.5 kb upstream of APOB. To further investigate the association signal of rs7575840, we first tested the SNP for association with refined lipid levels and proton nuclear magnetic resonance spectroscopy measurements of lipid particles in the Finnish population sample METSIM. Table 1 shows that the rare allele T (minor allele frequencyϭ28%) of rs7575840 is significantly associated with elevated apoB, LDL-C, and TC levels in METSIM (nϭ7710), with apoB providing the most significant evidence of association (Pϭ4.85ϫ10 Ϫ10 ). The proportion of a 1-SD change in standardized apoB residual values for each copy of the risk allele was 0.14, and the contribution of this genetic effect can explain 0.8% of the total variance of apoB levels in METSIM ( Table 1 ). The most associated lipid particles were the very small VLDL, intermediate lipoproteins, and all the LDL subclasses (Pϭ2ϫ10 Ϫ5 to 9ϫ10 Ϫ7 ) ( Supplemental Table I ). Among the tested lipoprotein subclasses, rs7575840 explains the most variance for these same subclasses (Supplemental Figure I) . Furthermore, the strongest signals classified by positive ␤ were also observed for the VLDL, intermediate lipoprotein, and LDL subclasses (␤ϭ8ϫ10 Ϫ3 to 3ϫ10 Ϫ2 ) ( Supplemental Table I ).
Different populations may have different signals because of the underlying differences in LD. To investigate whether the effect of rs7575840 on serum apoB levels also extends to another population, we first fine mapped the APOB gene region (Ϯ100 kb) by genotyping 43 SNPs in the Mexican dyslipidemic study sample (nϭ2310). By using the white HapMap CEU samples and the Mexican apoB controls (apoB levels Ͻ50 th age/sex-specific Mexican population percentile), we first observed that the LD pattern in whites closely resembles the LD in Mexicans (Supplemental Figure II) . When testing the 43 SNPs for association with apoB, we observed 4 nonredundant independent signals (r 2 Ͻ0.6) passing the Bonferroni correction (PϽ0.001) (Supplemental Table II and Supplemental Figure II ). Among the 43 tested SNPs, rs693, rs1367117, and rs7575840, which have been implicated in previous GWAS for LDL-C, 11, 12 provided strong evidence of association with apoB, although rs1367117 and rs7575840 represent redundant signals, as described below. The probability values for these 3 SNPs were ranked in the top 5 for all 3 tested traits, apoB, LDL-C, and TC ( Supplemental Tables II to IV) . To further validate these associations, we extended the genotyping of rs693, rs1367117, and rs7575840 to 356 additional Mexican dyslipidemic samples available for study (total nϭ2666, Table 2 ), which further strengthened the association signals for apoB (probability values of 2.90ϫ10 Ϫ6 , 6.83ϫ10 Ϫ6 , and 3.33ϫ10 Ϫ5 , explaining 0.74%, 0.90%, and 0.76% of the apoB levels, respectively). The LDL-C and TC traits provided somewhat less significant probability values (Table 2) . Interestingly, rs1367117 is a nonsynonymous SNP (Thr71Ile) in APOB. However, according to the Vista browser, the amino acid Thr71 is conserved only in mammals, and furthermore, the amino acid change Thr71Ile was previously predicted to be benign using the PolyPhen, SIFT, and PANTHER algorithms. 13 The SNP rs693 is a synonymous variant. It is worth noting that the association signals were all for the same risk allele as in whites. Hence, our results suggest that these white GWAS signals extend to the Mexican population.
We next investigated the pairwise LD of rs7575840 with all other SNPs in the APOB gene region (Ϯ100 kb) using the white HapMap CEU sample and Mexican apoB controls (Supplemental Figure III) . We observed that the regional differences in pairwise LD between the 2 populations are not large (Supplemental Figure III) . The SNP rs693 was not in strong LD with rs7575840 or rs1367117 (r 2 Ͻ0.55 both in Linear regression was performed on the METSIM cohort using an additive model. The effect allele is the allele associated with an increased trait value. Variance explained represents the percentage of the overall variation in the standardized residuals that can be attributed to the additive model. *␤ represents the proportion of 1 SD change in standardized trait values for each copy of the rare allele. †Standard error of ␤. HapMap CEU and Mexican apoB controls). The pairwise LD (using r 2 ) between rs7575840 and rs1367117 in the Mexican apoB controls was 0.80, and it was 0.91 in the CEU HapMap sample, indicating that in both populations, rs7575840 and rs1367117 are proxies, likely reflecting the same functional signal.
Mexicans are an admixed population that descends from a recent mix of Amerindian and European ancestry, with a small proportion of African ancestry. 14, 15 Population admixture may confound allelic association if both the trait distribution and the allele frequency differ between ancestries. We previously demonstrated that the apoB distribution did not differ with individual ancestry estimates in 2310 subjects of the Mexican hypertriglyceridemia cases and controls. 5 However, to further eliminate the possibility of spurious associations due to admixture, we also performed the association analyses of rs7575840, rs1367117, and rs693 while including individual ancestry estimates as a covariate in the regression model. In these adjusted analyses, we obtained probability values of 3.76ϫ10 Ϫ5 , 6.55ϫ10 Ϫ6 , and 1.30ϫ10 Ϫ6 for residual apoB levels, respectively, suggesting that the associations are not confounded by population admixture.
As rs7575840 resides 6.5 kb upstream of APOB, it may modify regulatory elements. To investigate whether rs7575840 affects the expression of APOB or transcripts in the APOB gene region, we searched for gene expression probes within 500 kb of APOB. The APOB probe ILMN_1664024, which corresponds with the APOB refseq ID NM_000384, was expressed in the 175 METSIM samples. No other expressed probes were observed within 500 kb of APOB on the microarray. We also tested a local transcript BU630349 for differential expression between the rs7575840 genotypes by reverse transcriptionpolymerase chain reaction, because it was previously found to be significantly differentially expressed on the basis of the rs7575840 genotypes (ie, cis-expression quantitative trait locus) in liver (Pϭ1.62ϫ10 Ϫ54 ), passing a multiple testing correction of false discovery rate Ͻ10%. 16 No effect was observed between the rs7575840 genotypes and APOB expression in liver. 16 BU630349 is a 662-bp-long predicted noncoding RNA located 872 bp upstream of APOB and conserved in primates. To ensure that we did not obtain spurious associations due to a small number of homozygous individuals, we used a dominant model to test for cis-expression quantitative trait locus. The METSIM subjects carrying at least 1 minor allele of rs7575840 had significantly more APOB expression (Pϭ1.13ϫ10 Ϫ10 ) and BU630349 expression (Pϭ7.86ϫ10 Ϫ6 ) in adipose tissue relative to the homozygous common group (Figures 1 and 2) . The fold change between the 2 groups was 1.17ϫ for APOB and 1.78ϫ for BU630349, with rs7575840 explaining 21.5% and 11.2% of the APOB and BU630349 variance, respectively (Figures 1 and 2) . The associations were also significant using an additive model (Pϭ5.37ϫ10 Ϫ9 for APOB, Pϭ2.18ϫ10 Ϫ6 for BU630349). The detected APOB differential expression is in line with the observation that individuals with the rare allele of rs7575840 have higher serum apoB levels (Table 1) .
To determine whether expression of APOB or BU630349 may be related to lipoprotein subclasses, we performed Pearson correlations in the 175 METSIM fat biopsy samples. Both expression of APOB and expression of BU630349 were positively correlated with high-density lipoprotein cholesterol concentration/particles and negatively correlated with triglycerides and VLDL concentration/particles ( Supplemental Figure IV) . We also observed that raw serum apoB levels were negatively correlated with APOB expression in adipose tissue (Pϭ0.005, rϭϪ0.21).
To search for a possible mechanism of how rs7575840 influences APOB and BU630349 expression, we performed in silico analysis using the PROMO program to search for tran- scription factor binding sites that differ based on the rs7575840 genotype. We found that the major allele uniquely codes for a transcription factor binding site for CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta transcription factors, and the minor allele codes for a YY1 transcription factor binding site. CEBPA expression was positively correlated with APOB (rϭ0.50, Pϭ1.57ϫ10 Ϫ12 ) and BU630349 expression (rϭ0.21, Pϭ6.91ϫ10 Ϫ3 ) in the 175 METSIM adipose RNA samples. This is in line with the fact that APOB and BU630349 expression were also correlated in adipose tissue (rϭ0.49, Pϭ1.46ϫ10 Ϫ11 ). After the rs7575840 genotype was used as a covariate, the correlations between CEBPA and APOB were stronger and Ϸ1000 times more significant (rϭ0.56 and Pϭ8.38ϫ10 Ϫ16 for additive model; rϭ0.58 and Pϭ6.92ϫ10 Ϫ17 for dominant model). The correlation between CEBPA and BU630349 was slightly stronger when the rs7575840 genotype was corrected for (rϭ0.24 and Pϭ1.97ϫ10 Ϫ3 for additive genotype; rϭ0.23 and Pϭ2.42ϫ10 Ϫ3 for dominant genotype). SNP rs7575840 was not significantly associated with CEBPB or YY1 expression. CEBPA and CEBPB were positively correlated with each other (rϭ0.37, Pϭ 3.30ϫ10 Ϫ7 ). Taken together, our in silico and gene expression data suggest that rs7575840 may affect APOB and BU630349 expression in adipose tissue by influencing a CEBPA binding site.
Discussion
Our data in 2 different populations, Finns and Mexicans, implicate the rs7575840 variant near the APOB gene for apoB, LDL-C, and TC levels, the most affected traits in our analyses being apoB and apoB-containing lipid particles. Furthermore, our novel data also revealed a possible functional mechanism by which rs7575840 influences apoB, LDL-C, and TC levels, by altering the expression level of the APOB gene itself and a regional noncoding RNA (BU630349) in adipose tissue. The latter has also been shown to be differentially expressed by rs7575840 in 427 liver samples. 16 A nonsynonymous SNP, rs1367117, that has also been identified in a recent GWAS metaanalysis for LDL-C 1 is in high LD with rs7575840 both in whites and Mexicans. Our functional findings suggest a mechanism how these redundant, genome-wide significant GWAS signals, rs7575840 and rs1367117, may alter apoB levels.
Variants in APOB have been investigated for associations with lipids in multiple previous candidate gene studies, mostly based on white populations. 13, 17, 18 In a recent white mega-metaanalysis GWAS of mainly population-based samples, the amino acid change rs1367117 in APOB resulted in a probability value of 4.48ϫ10 Ϫ114 for LDL-C in 95 402 subjects, whereas rs7575840 (LDϭ0.9 by r 2 ) resulted in a probability value of 1.67ϫ10 Ϫ98 for LDL-C in 41 912 subjects. 1 It is important to confirm whether the known loci have a consistent effect across ethnic groups to determine which variants are to be used in cardiovascular risk assessment. Furthermore, despite the high prevalence of high LDL-C (46%) in Mexicans, 2 little is known about the genetic factors predisposing to high cholesterol levels in this population. Our transethnic fine mapping shows the first replication of these 2 GWAS variants and another previous GWAS variant, rs693, 11 in the Mexican population with a high susceptibility to dyslipidemia.
The recent white mega-GWAS study 1 focused on TC and LDL-C, whereas apoB levels were not available for the study. Although we also obtained significant association evidence for TC and LDL-C, we observed the strongest association signal with apoB. ApoB is the sole protein component of LDL particles and is present in most atherogenic lipoprotein particles. Previous prospective epidemiological studies have clearly shown that apoB levels predict the risk of coronary artery disease better than LDL-C and TC levels. 19 Our study demonstrates that rs7575840 is associated with VLDL, intermediate lipoproteins, and LDL subclasses. These data further implicate the role of rs7575840 or SNPs in LD with it in apoB metabolism.
Discovering the underlying mechanisms behind GWAS signals has been very difficult, largely because of large LD blocks, spanning many genes, and the absence of functional evidence provided by the GWAS. To search for a possible function of rs7575840, we used 1 of the largest subcutaneous fat biopsy gene expression cohorts published to date (nϭ175). Because adipose tissue is an important regulator of lipid metabolism in humans, we decided to determine whether the rs7575840 genotype alters gene expression in this tissue. We discovered that rs7575840 is associated with APOB and BU630349 expression in adipose tissue, providing possible regulatory mechanisms by which this SNP may alter apoB, LDL-C, and TC levels. Importantly, the same cisexpression quantitative trait locus between rs7575840 and BU630349 has previously been observed in liver, although the APOB expression did not differ between the rs7575840 genotypes. 16 Differences in the microarray platforms used may have contributed to these discrepancies. However, even though the hepatic APOB expression did not differ between the rs7575840 genotypes, the regional noncoding RNA BU630349 may still serve as a posttranscriptional regulator of APOB, because besides expression, long noncoding RNAs may affect splicing, transport, translation, and epigenetic regulation of genes. 20 Interestingly, we also found that the binding site of a transcription factor, CEBPA, is predicted to differ based on the rs7575840 genotypes, and its expression was positively correlated with APOB and BU630349 expression in the 175 METSIM adipose RNA samples. CEBPA is highly expressed both in adipose tissue and liver, is known to modulate leptin and adiponectin expression, and induces expression of genes involved in differentiation of granulocytes, monocytes, adipocytes, and hepatocytes. 21, 22 Future studies are warranted to determine the detailed molecular mechanisms by which rs7575840 or SNPs in LD with it ultimately affect apoB levels. Nevertheless, taken together, our data provide the first piece of evidence of how rs7575840 influences apoB and apoB-containing lipid particles.
